Neuralink Knew Brain Chip Was Faulty ‘For Years’ But Implanted It Anyway
Tesla boss Elon Musk has his fingers in quite a few pies these days, with half his mind working to improve electric vehicles for the masses, some of it working …
Pharma
Q4 results today: Tata Motors, Cipla among 87 companies to announce earnings
As many as 87 companies will announce their quarterly results for the January-March 2024 period on Friday. Some of the big companies that investors’ will watch closely are Tata Motors, …
Car Seat Foam Could Expose You To Carcinogens, By The Way
It seems like everything causes cancer these days, and now researchers are learning how our cars may expose us all to potentially cancer-causing chemicals. As it turns out, some of …
What to expect from the Indian stock market next week? Ashi Anand answers
“IT is weak. Banking, you are seeing a bit muted, not so much because of growth or asset quality, but because margins are under some level of pressure,” says Ashi …
Elon Musk’s Neuralink Cause For ‘A Lot Of Concern’: Doctors
Neuralink, Billionaire Elon Musk’s tiny side hustle and dating service, began brain-computer interface implant long-term trials in human subjects late last month, the third such company to do so. There …
corporate results: Q3 Results: How did 5 key sectors perform during the quarter?
As the results for the Oct-Dec quarter are unveiled, insights from management commentaries across various sectors provide valuable indicators of the Indian economy’s health. Businesses serve as the backbone of …
Which One Of You Blue Check Guys Let Elon Musk Put A Chip In Your Brain?
Photo: Slaven Vlasic (Getty Images) Elon Musk announced that Neuralink has implanted a computer chip in the brain of its first human patient. Tesla’s Cybertruck Has Finally Arrived Neuralink implanted …
stocks to buy now: Looking for hidden gems? Look into these 3 sectors: Anshul Saigal
Anshul Saigal, Founder, Saigal Capital, says “one should really focus on bottom-up opportunities, not worry about the market levels, market direction. As long as we have got good companies at …
Pharma: Pharma cos’ likely re-rating, strong outlook to sustain rally
Mumbai: The recent strength in the shares of pharmaceutical companies that has lifted many of them to yearly highs may have more legs over the next year. With various shares …
Sun Pharma: Sun Pharma’s focus on specialty drugs pays off
Even as the raw material cost climbed down from 25% of revenues a year ago to 23% in the September quarter, the other expenses increased from 28% of revenues to …